12
/L, Hb 6.1 g/dL, MCV 92 fl. No signs of hemolysis or other common causes of anemia were found.
Anemia was treated with erythropoietin, with no success. Transfusion induced transient correction of anemia. A few days later, during an upper respiratory infection with diarrhea, albumin was 18.7 g/L; PT/INR 1.19. Sweat chloride test (102-106 mmol/L) suggested CF, confirmed by mutation analysis (Phe508del/2183AA > G) despite negative screening for CF at birth.
Replacement therapy with pancreatic enzymes was started: anemia and stools normalized and the child gained weight.
We retrospectively reviewed our files and identified a 3-month old girl with poor growth and severe dermatitis. CBC showed RBC 1.90 × 10 12 /L, Hb 5.5 g/dL, MCV 101 fL. Her brother was heterozygous for CF Phe508del mutation.
A single erythrocyte transfusion induced transient correction of anemia. Concurrent hypoalbuminemia (16.2 g/L) was treated with replacement therapy. Since dermatitis progressed, fecal chymotrypsin level was found 1 U/g. CF was diagnosed based on sweat chloride test (95-94 mmol/L) and evidence of Phe508del. Replacement therapy with pancreatic enzymes improved anemia and dermatitis.
Phe508del was present in 7/17 Sismanlar's patients and in our cases. This may suggest the need for a wider genotypephenotype evaluation.
